A Polyvalent Peptide CD40 Nanoagonist for Targeted Modulation of Dendritic Cells and Amplified Cancer Immunotherapy.
Mamuti M, Wang Y, Zhao YD, Wang JQ, Wang J, Fan YL, Xiao WY, Hou DY, Yang J, Zheng R, An HW, Wang H.
Mamuti M, et al. Among authors: wang h, wang j, wang y, wang jq.
Adv Mater. 2022 Jun;34(24):e2109432. doi: 10.1002/adma.202109432. Epub 2022 May 12.
Adv Mater. 2022.
PMID: 35426184